Zhen Wu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Chronic Kidney Disease

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yifan Lv, Yuxuan Deng, Jie Feng, Jinqiu Liu, Mingxu Yang, Zhuonan Pu, Shaodong Zhang, Zhen Wu, Nan Ji, Deric M Park, Shuyu Hao
NAD+ metabolic enzyme inhibitor as radiosensitizer for malignant meningioma and its modulation of P53 expression. Molecular cancer therapeutics (2024)
Xulei Huo, Yali Wang, Sihan Ma, Sipeng Zhu, Ke Wang, Qiang Ji, Feng Chen, Liang Wang, Zhen Wu, Wenbin Li
Multimodal MRI-based radiomic nomogram for predicting telomerase reverse transcriptase promoter mutation in IDH-wildtype histological lower-grade gliomas. Medicine 102 (51) (2023)
Xulei Huo, Yali Wang, Sihan Ma, Sipeng Zhu, Ke Wang, Qiang Ji, Feng Chen, Liang Wang, Zhen Wu, Wenbin Li
Multimodal MRI-based radiomic nomogram for predicting telomerase reverse transcriptase promoter mutation in IDH-wildtype histological lower-grade gliomas. Medicine 102 (51) (2023)
Lairong Song, Xu-Lei Huo, Xiaojie Li, Xiaoying Xu, Yi Zheng, Da Li, Jun-Ting Zhang, Ke Wang, Liang Wang, Zhen Wu
SERPINF1 Mediates Tumor Progression and Stemness in Glioma. Genes 14 (3) (2023)
Lairong Song, Xu-Lei Huo, Xiaojie Li, Xiaoying Xu, Yi Zheng, Da Li, Jun-Ting Zhang, Ke Wang, Liang Wang, Zhen Wu
SERPINF1 Mediates Tumor Progression and Stemness in Glioma. Genes 14 (3) (2023)
Lairong Song, Xu-Lei Huo, Xiaojie Li, Xiaoying Xu, Yi Zheng, Da Li, Jun-Ting Zhang, Ke Wang, Liang Wang, Zhen Wu
SERPINF1 Mediates Tumor Progression and Stemness in Glioma. Genes 14 (3) (2023)